Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Acute Kidney Injury | Research article

The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis

Authors: Yi Chen, Liyu Lin, Xuan Tao, Yankun Song, Jiong Cui, Jianxin Wan

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

To establish a model of chronic renal fibrosis following acute kidney injury (AKI) in BALB/c mice and to observe the effect of AKI on podocyte injury and chronic fibrosis of the kidney. Additional aims included using the model to explore the role of podocyte injury in AKI and post-injury fibrosis.

Methods

Fifty BALB/C mice were randomly divided into control group (Ctr), sham group (sham), AKI 20 group (renal ischemia, 20 min reperfusion), AKI 30 group (renal ischemia, 30 min reperfusion) and AKI 40 group (renal ischemia, 40 min reperfusion). Mice serum and 24-h urine were collected on the 8th, 9th, 10th, 14th, and 28th days for urinary protein, serum creatinine (Scr) and blood urea nitrogen (BUN) analysis. HE staining, transmission electron microscopy (TEM), Masson staining, Q-PCR, Western Blot and immunohistochemistry were applied.

Results

Serum Scr and BUN levels across all AKI groups at the 9th day were significantly higher (P < 0.05) than controls, with higher reperfusion groups maintaining that increase up to 28 days (P < 0.05). Compared with Ctr group, the urinary protein of the AKI 40 group significantly rose on the 9th day (P < 0.05), normalizing immediately on the 10th day (P < 0.05). In contrast, the AKI 30 group rose significantly on the 14th day (P < 0.05) maintaining elevated levels for two weeks (P < 0.05). HE staining demonstrated ischemia-dependent renal tissue damage was aggravated in the mild to aggravated AKI groups. Mesangial proliferation, glomerulosclerosis, and tubulointerstitial pathology were also significantly increased in these groups (P < 0.05). Masson staining further showed that glomerular, renal tubular, and interstitial collagen were increased by ischemia in a time-dependent manner. Transmission EM additionally that podocytes of the mild to severe AKI groups displayed extensive fusion, exfoliation and GBM exposure. Synaptopodin, Nephrin, and CD2AP mRNA and protein expression demonstrated ischemic time-dependent decreases, while the TRPC6 was increased. There was a significant difference in the levels of Synaptopodin, Nephrin, CD2AP, and TRPC6 between the mild and severe AKI groups (P < 0.05).

Conclusions

1) During the AKI process mice podocyte injury, proteinuria and the subsequent progression into chronic renal fibrosis is observed.2) Podocyte injury may be one of the causes of ischemia-reperfusion acute kidney injury and post-injury fibrosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease [J]. Lancet. 2017;389(10075):1238–52.CrossRef Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease [J]. Lancet. 2017;389(10075):1238–52.CrossRef
2.
go back to reference Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.CrossRef Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.CrossRef
3.
go back to reference Fang Y, Teng J, Ding X. Acute kidney injury in China.[J]. Hemodial Int. 2015;19(1):2–10.CrossRef Fang Y, Teng J, Ding X. Acute kidney injury in China.[J]. Hemodial Int. 2015;19(1):2–10.CrossRef
4.
go back to reference Hingorani S, Molitoris BA, Himmelfarb J. Ironing out the pathogenesis of acute kidney injury. Am J Kidney Dis. 2009;53(4):569–71.CrossRef Hingorani S, Molitoris BA, Himmelfarb J. Ironing out the pathogenesis of acute kidney injury. Am J Kidney Dis. 2009;53(4):569–71.CrossRef
5.
go back to reference Coca SG, Yusuf B, Shlipak MG, et al. Long- term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta- analysis. Am J Kidney Dis. 2009;53:961–73.CrossRef Coca SG, Yusuf B, Shlipak MG, et al. Long- term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta- analysis. Am J Kidney Dis. 2009;53:961–73.CrossRef
6.
go back to reference Horne KL, Packington R, Monaghan J, et al. Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study. BMJ Open. 2017;7:e015316.CrossRef Horne KL, Packington R, Monaghan J, et al. Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study. BMJ Open. 2017;7:e015316.CrossRef
7.
go back to reference Greenberg JH, Coca S, Parikh CR. Long- term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review [J]. BMC Nephrol. 2014;15:184.CrossRef Greenberg JH, Coca S, Parikh CR. Long- term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review [J]. BMC Nephrol. 2014;15:184.CrossRef
8.
go back to reference Peng Y, Zhang X, Wang Y, et al. Overexpression of toll-like receptor 2 in glomerular endothelial cells and podocytes in septic acute kidney injury mouse model. [J]. Ren Fail. 2015;37(4):694–8.CrossRef Peng Y, Zhang X, Wang Y, et al. Overexpression of toll-like receptor 2 in glomerular endothelial cells and podocytes in septic acute kidney injury mouse model. [J]. Ren Fail. 2015;37(4):694–8.CrossRef
9.
go back to reference Kraft SW, Schwartz MM, Korbet SM, et al. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am SocNephrol. 2005;16(1):175–9. Kraft SW, Schwartz MM, Korbet SM, et al. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am SocNephrol. 2005;16(1):175–9.
10.
go back to reference Skrypnyk NI, Harris RC, de Caestecker MP.Ischemia-reperfusion model of acute kidney injury and post injury fibrosis in mice. J Vis Exp. 2013;(78):50495. Skrypnyk NI, Harris RC, de Caestecker MP.Ischemia-reperfusion model of acute kidney injury and post injury fibrosis in mice. J Vis Exp. 2013;(78):50495.
12.
go back to reference Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury:a global perspective of a silent killer. Kidney Int. 2013;84(3):457–67.CrossRef Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury:a global perspective of a silent killer. Kidney Int. 2013;84(3):457–67.CrossRef
13.
go back to reference Susantitaphong P, Cruz DN, Cerda J, et al. Acute Kidney Injury Advisory Group of the American Society of Nephrology. World incidence of AKI:a meta-analysis. Clin J Am SocNephrol. 2013;8(9):1482–93.CrossRef Susantitaphong P, Cruz DN, Cerda J, et al. Acute Kidney Injury Advisory Group of the American Society of Nephrology. World incidence of AKI:a meta-analysis. Clin J Am SocNephrol. 2013;8(9):1482–93.CrossRef
14.
go back to reference Mammen C, Al Abbas A, Skippen P, et al. Long- term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. [J]. Am J Kidney Dis. 2012;59(4):523–30.CrossRef Mammen C, Al Abbas A, Skippen P, et al. Long- term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. [J]. Am J Kidney Dis. 2012;59(4):523–30.CrossRef
15.
go back to reference Hara S, Kobayashi N, Sakamoto K, et al. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol. 2015;185(8):2118–31.CrossRef Hara S, Kobayashi N, Sakamoto K, et al. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol. 2015;185(8):2118–31.CrossRef
16.
go back to reference Guan N, Ren YL, Liu XY, et al. Protective role of cyclosporine a and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin. Nephrol Dial Transplant. 2015;30(6):957–69.CrossRef Guan N, Ren YL, Liu XY, et al. Protective role of cyclosporine a and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin. Nephrol Dial Transplant. 2015;30(6):957–69.CrossRef
17.
go back to reference Singh AP, Junemann A, Muthuraman A, et al. Animal models of acute renal failure. Pharmacological reports: PR. 2012;64:31–44.CrossRef Singh AP, Junemann A, Muthuraman A, et al. Animal models of acute renal failure. Pharmacological reports: PR. 2012;64:31–44.CrossRef
18.
go back to reference Shi M, Flores B, Gillings N, et al. αKlotho mitigates progression of AKI to CKD through activation of autophagy. J Am SocNephrol. 2016;27(8):2331–45. Shi M, Flores B, Gillings N, et al. αKlotho mitigates progression of AKI to CKD through activation of autophagy. J Am SocNephrol. 2016;27(8):2331–45.
19.
go back to reference Le Clef N, Verhulst A, D’Haese PC, et al. Unilateral renal ischemia-reperfusion as a robust model for acute to chronic kidney injury in mice. PLoS One. 2016;11(3):e0152153.CrossRef Le Clef N, Verhulst A, D’Haese PC, et al. Unilateral renal ischemia-reperfusion as a robust model for acute to chronic kidney injury in mice. PLoS One. 2016;11(3):e0152153.CrossRef
20.
go back to reference Kestila M, Lenkkeri U, Mannikko M, et al. Positionallyclonedgene for a novelglomerularproteinnephrin is mutated in congenitalnephriticsyndrome. Mol Cell. 1998;1(4):575–82.CrossRef Kestila M, Lenkkeri U, Mannikko M, et al. Positionallyclonedgene for a novelglomerularproteinnephrin is mutated in congenitalnephriticsyndrome. Mol Cell. 1998;1(4):575–82.CrossRef
21.
go back to reference Patari A, Forsblom C, Havana M, et al. Nephrinuria in diabeticnephropathy of type 1 diabetes. Diabetes. 2003;52(12):2969–74.CrossRef Patari A, Forsblom C, Havana M, et al. Nephrinuria in diabeticnephropathy of type 1 diabetes. Diabetes. 2003;52(12):2969–74.CrossRef
22.
go back to reference Hauser PV, Collino F, Bussolati B, et al. Nephrin and endothelialinjury. CurrOpinNephrol. Hypertens. 2009;18(1):3–8. Hauser PV, Collino F, Bussolati B, et al. Nephrin and endothelialinjury. CurrOpinNephrol. Hypertens. 2009;18(1):3–8.
23.
go back to reference Li X, Chuang PY, D'Agati VD, et al. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys. J Am SocNephrol. 2015;26(10):2361–77. Li X, Chuang PY, D'Agati VD, et al. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys. J Am SocNephrol. 2015;26(10):2361–77.
24.
go back to reference Shaw AS, Miner JH. CD2-associated protein and the kidney. Curr Opin Nephrol Hppertens. 2001;10(1):19–22.CrossRef Shaw AS, Miner JH. CD2-associated protein and the kidney. Curr Opin Nephrol Hppertens. 2001;10(1):19–22.CrossRef
25.
go back to reference Gigante M, Pontrelli P, Montemurno E, et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)[J]. Nephrol Dial Transplant. 2009;24(6):1858–64.CrossRef Gigante M, Pontrelli P, Montemurno E, et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)[J]. Nephrol Dial Transplant. 2009;24(6):1858–64.CrossRef
26.
go back to reference Tsuji K, Păunescu TG, Suleiman H, et al. Re-characterization of the Glomerulopathy in CD2AP deficient mice by high-resolution helium ion scanning microscopy. Sci Rep. 2017 Aug 16;7(1):8321.CrossRef Tsuji K, Păunescu TG, Suleiman H, et al. Re-characterization of the Glomerulopathy in CD2AP deficient mice by high-resolution helium ion scanning microscopy. Sci Rep. 2017 Aug 16;7(1):8321.CrossRef
27.
go back to reference Mundel P, Heid HW, Mundel TM, et al. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes [J]. J Cell Biol. 1997;139(1):193–204.CrossRef Mundel P, Heid HW, Mundel TM, et al. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes [J]. J Cell Biol. 1997;139(1):193–204.CrossRef
28.
go back to reference Zuo Y, Yang HC, Potthoff SA, et al. Protective effects of PPAR gamma agonist in acute nephritic syndrome [J]. Nephrol Dial Transplant. 2012;27(1):174–81.CrossRef Zuo Y, Yang HC, Potthoff SA, et al. Protective effects of PPAR gamma agonist in acute nephritic syndrome [J]. Nephrol Dial Transplant. 2012;27(1):174–81.CrossRef
29.
go back to reference Wagrowska-Danilewicz M, Danilewicz M. Synaptopodin immune expression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis [J]. Nefrologia. 2007;27(6):710–5.PubMed Wagrowska-Danilewicz M, Danilewicz M. Synaptopodin immune expression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis [J]. Nefrologia. 2007;27(6):710–5.PubMed
30.
go back to reference Yu H, Kistler A, Faridi MH, et al. Synaptopodin limits TRPC6 podocyte surface expression and attenuates proteinuria. J Am SocNephrol. 2016;27(11):3308–19. Yu H, Kistler A, Faridi MH, et al. Synaptopodin limits TRPC6 podocyte surface expression and attenuates proteinuria. J Am SocNephrol. 2016;27(11):3308–19.
31.
go back to reference Wiggins RC. The spectrum of podocytopathies: a uniting view of glomerular diseases. Kidney Int. 2007;71(12):1205–14.CrossRef Wiggins RC. The spectrum of podocytopathies: a uniting view of glomerular diseases. Kidney Int. 2007;71(12):1205–14.CrossRef
32.
go back to reference Huang H, You Y, Lin X, et al. Inhibition of TRPC6 signal pathway alleviates podocyte injury induced by TGF-β1. Cell PhysiolBiochem. 2017;41(1):163–72. Huang H, You Y, Lin X, et al. Inhibition of TRPC6 signal pathway alleviates podocyte injury induced by TGF-β1. Cell PhysiolBiochem. 2017;41(1):163–72.
Metadata
Title
The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis
Authors
Yi Chen
Liyu Lin
Xuan Tao
Yankun Song
Jiong Cui
Jianxin Wan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1298-x

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.